There are no previous study about ocular toxoplasmosis and serum levels of dehydroepiandrosterone sulphated hormone (DHEAS). We use the chemoluminiscence automatized Immulite assay to determine the levels of DHEAS. Four groups were studied: (1) Individuals with chronic asymptomatic infection with a positive test for IgG anti-Toxoplasma and without ocular lesions (n Z 16); (2) Chronic asymptomatic patients with retinal scars of retinochoroiditis by Toxoplasma (n Z 19); (3) Acute symptomatic patients with active retinochoroiditis by Toxoplasma (n Z 26); (4) Individuals with negative assays for IgG anti-Toxoplasma (n Z 21). Comparison of DHEAS levels between groups were adjusted by age and sex and nonparametric Kruskall Wallis statistical tests were applied. No significant differences in serum levels of DHEAS were found between groups when age and sex were controlled. DHEAS levels were not significantly different in active ocular toxoplasmosis related to non active or non infected persons.
Introduction
Ocular toxoplasmosis is the most common infectious cause of retinochoroidal inflammation in immunocompetent individuals and is one of the most important causes of visual damage in some countries. 1 Thus, in Colombia, it is estimated that 6% of the population has retinochoroidal scars after a non congenital infection and 20% of these persons have reduced visual capacity. 2 Recurrent retinochoroiditis is a typical characteristic of ocular toxoplasmosis and the factors related to this remain to be discovered. 3 In a field study in Brazil, a relation between puberty, gender and apparition of new lesions in ocular toxoplasmosis was described. 4 A hormonal factor triggering recurrences has been evocated but the precise hormones linked to these events have not been studied.
In recent years there has been strong speculation that puberty-related hormones, dehydroepiandrosterone (DHEA) in particular, might play some role in inducing resistance during Schistosoma, HIV and malaria infections.
5e7 DHEA is one of the steroid hormones produced by the adrenal cortex and is found mostly in its sulfate form, DHEA sulfate (DHEAS); it is converted to DHEA by DHEA sulfatase. 8 The secretion of DHEAS is high just before birth and again at puberty, and the maximum concentration is reached at around 20 to 30 years of age, followed by a progressive decline with age. DHEAS is implicated in age-related changes in the immune system and has been associated with disease susceptibility. 9 To our knowledge, no report has been made of the DHEAS levels during human toxoplasmosis
Materials and methods

Patients
Four groups of patients were studied: (1) acute symptomatic patients with active retinochoroiditis by Toxoplasma (n Z 26); (2) chronic asymptomatic patients with retinal scars of retinochoroiditis by Toxoplasma (n Z 19); (3) individuals with chronic asymptomatic infection with a positive test for anti-Toxoplasma IgG and without ocular lesions (n Z 16); and (4) individuals with negative assays for anti-Toxoplasma IgG (n Z 21). Diagnosis criteria for active retinochoroiditis and chronic inactive retinal scar were as described previously. 2 Patients without ocular lesions but with positive Toxoplasma serology and those without ocular lesions but negative for Toxoplasma serology were volunteers identified during fundoscopy ocular screening at the University of Quindio.
2 Anti-Toxoplasma IgG antibodies were measured by the Enzyme-Linked Immunosorbent Assay (ELISA) Test (Diagnostic Systems Laboratories Inc, Webster, Texas, USA).
Determination of DHEAS
DHEAS was measured with an immunoluminometric assay (DPC, Los Angeles, USA) with an intra-assay coefficient of variation of 9%. Levels were expressed in mg/dL. 
Statistical analysis
Comparisons of DHEAS levels between groups were stratified by age and sex and non-parametric Kruskall Wallis statistical tests were applied. The Epi-info computer programme (CDC, Atlanta, Georgia, USA) was used for analysis of data.
Results and discussion
Levels of DHEAS were significantly different between women (median Z 73 mg/dL, range 15e70 mg/dL) and men (184 mg/dL, range 39e520 mg/dL). Subsequent analyses were made separately for men and women. We compared patients with ocular lesions with active inflammatory retinochoroidal lesion by Toxoplasma versus patients with an inactive toxoplasmic retinochoroidal scar and patients without ocular lesion but positive Toxoplasma serology versus patients without ocular lesion and negative Toxoplasma serology. Age means were not different between the groups with the exception of women without ocular lesions. Therefore, for these two groups of women (positive versus negative Toxoplasma serology), comparisons of DHEAS levels were made only between women with an age range of 20 years to 30 years. As shown in Fig. 1 , DHEAS levels were higher between the ages of 20 years and 40 years. No significant differences of DHEAS levels were found by comparing the groups of active versus inactive chorioretinal lesions or in people without ocular lesions between positive or negative Toxoplasma serology (Tables 1 and 2 ). There were no significant differences between the active or inactive lesions in ocular toxoplasmosis or in infected versus non infected patients with Toxoplasma. DHEAS levels were significantly affected by age and sex; when we controlled the groups for comparison, no differences were found with regards to the infection status. Interestingly, the two higher values for DHEAS in all groups were found in two patients (one male, one female) with active chorioretinal Toxoplasma lesions.
Although the intrinsic correlation of DHEAS and the immune system merits further exploration 10 regarding the role of this hormone in human toxoplasmosis, our present results indicate that the levels of DHEAS are not useful to indicate activity and that they are not altered significantly in ocular toxoplasmosis. Serum DHEAS in ocular toxoplasmosis
